Ylva Tiblom Ehrsson on Muck Rack

Ylva Tiblom Ehrsson

As seen in: Nature, MDPI, European Journal of Oncology Nursing
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ylva Tiblom

Contact Ylva Tiblom, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Early and late mortality among patients with T1–T3 head and neck squamous cell carcinoma: a machine learning analysis using a SEER population-based cohort study

|
By Rasheed Omobolaji Alabi, Orlando Guntinas-Lichius, Mohammed Elmusrati, Alhadi Almangush, Ylva Tiblom Ehrsson, Göran Laurell, Antti Mäkitie, Mahmoud Bazina
| Nature Verified
Abstract Despite advances in the management of head and neck squamous cell carcinoma (HNSCC), mortality within 6 months of diagnosis remains a substantial clinical challenge.
Open in Who Shared Issue with article?

Predicting Return to Work after Head and Neck Cancer Treatment Is Challenging Due to Factors That Affect Work Ability

|
By Ylva Tiblom Ehrsson, Marta Kisiel, Göran Laurell, Yukai Yang
| MDPI
1. Introduction Striving to return to everyday life, including work, is of great importance to many cancer survivors, and the success rate is traditionally regarded as dependent on the site of the tumour, tumour stage, treatment, and comorbidities [1,2,3]. Head and neck cancer (HNC) includes a group of malignancies located at different sites in the upper aerodigestive tract, and squamous cell carcinoma (SCC) accounts for more than 90%.
Open in Who Shared Issue with article?

IJMS | Free Full-Text | Loco-Regional Control and Sustained Difference in Serum Immune Protein Expression in Patients Treated for p16-Positive and p16-Negative Head and Neck Squamous Cell Carcinoma

|
By Karl J. Sandstrom, Ylva Tiblom Ehrsson, Felix Sellberg, Hemming Johansson
| MDPI
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Open in Who Shared Issue with article?
See all 4 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified